Ultragenyx Pharmaceutical



Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Insmed USD -241795000 46.45M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Kyowa Hakko Kirin JPY 33.23B 2.39B 2024-09
MacroGenics USD 56.03M 112.4M 2024-09
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Ultragenyx Pharmaceutical - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.